Sharon Morriss Email

SVP, Clinical Development . lungtx.com

Current Roles

Employees:
22
Revenue:
$3.4M
About
Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of leading research in orphan, pulmonary indications for which there are unmet medical needs. The company is developing a proprietary pipeline of therapeutics with the potential to greatly improve outcomes over currently available treatments. The company's lead drug candidate, LTI-01, is in clinical development for Loculated Pleural Effusion (LPE) and has successfully completed a clinical trial in LPE patients. The company's second drug candidate, LTI-03, is in clinical development for Idiopathic Pulmonary Fibrosis (IPF).
lungtx.com Address
2600 Via Fortuna
Austin, TX
United States
lungtx.com Email

Past Companies

Lung Therapeutics, Inc.SVP, Clinical Development
Apellis PharmaceuticalsSVP, Clinical Development Operations
Apellis PharmaceuticalsVice President, Global Clinical Operations

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.